The first half of 2025 has confirmed a seismic shift in the pharmaceutical landscape: GLP-1 receptor agonists — a class of new drug therapies for diabetes and obesity — now dominate global sales charts. Among all medicines worldwide, treatments for
EC Innovations is proud to announce its inclusion in CSA Research’s 2025 list of the Top 30 global language service providers (LSPs), securing the #27 spot worldwide. This marks a major milestone in the company’s steady growth and expanding global
The biotech sector is on the cusp of a surge in novel therapies. Recent FDA approvals were driven by first-in-class drugs and expedited review paths. Nearly half of 50 new biologic and molecular therapies approved by 2024 will be first-in-class
EC Innovations, a leading global provider of language and localization services, is excited to announce a strategic partnership with Phrase, a global leader in AI-driven language technology. Together, the two companies will deliver comprehensive, technology-driven localization solutions to clients worldwide.
EC Innovations, a leading global provider of translation, localization, and interpreting services, proudly announces its breakthrough entry into the Top 30 of CSA Research’s 2025 Listing of Global Language Service Providers (LSPs). Based on verified revenue data from 2024, EC
Over the past decade, China’s biotech sector has surged onto the world stage in drug licensing. From just 55 China‐related deals in 2015, Chinese biopharma companies were involved in 213 deals by 2024. Total deal value jumped from $3.1 billion
Creating software that performs flawlessly is a major milestone, but sharing it with a global audience introduces new challenges. One of the most overlooked aspects of this transition is language. A user interface (UI) that supports only a single language
Nowadays, an increasing number of Chinese companies are actively expanding into overseas markets. In the process of going global, these enterprises have found that the environment they face is becoming increasingly complex and challenging due to factors such as geopolitics,
Have you faced these challenges in your localization projects? What may seem like small issues in translation—like inconsistent wording, repeated manual work, or mismatched terminology—can significantly slow down project timelines, increase costs, and damage your brand’s credibility. In multilingual localization,
Have you ever faced an embarrassing moment as a localization manager? In the rush of handling multilingual projects, it’s all too easy to confuse German with Dutch or Japanese with Chinese, disrupting the entire translation process. These mistakes lead to
AI is revolutionizing drug regulation at every stage—from speeding reviews to improving safety monitoring and replacing animal testing. Here’s a clear and engaging breakdown, complete with real-world examples: 1. Faster, Smarter Drug Reviews Elsa: FDA’s Generative AI Assistant In early
When you hear someone speaking Spanish in Spain, Mexico City, or Argentina, then you probably know that you’re listening to three distinctly different Spanish dialects of the same language. Yes, Spanish is a language spoken widely in South America, but
